Literature DB >> 3045260

Methadone maintenance to abstinence. How many make it?

J B Milby1.   

Abstract

This study imposed a set of decision rules to review and compare methadone maintenance detoxification research results in three 5-year eras since 1970. Variables of interest were detoxification completion rates, relative completion rates with and without program review and approval, psychotherapy, new pharmacological agents to accelerate the detoxification process, and abstinence rates at follow-up as a function of such treatment variables. The review found progressive improvement in overall detoxification completion rates over the three 5-year eras: 39.7%, 54.9%, and 76.3%. Program-recommended detoxification showed much higher completion rates than did unrecommended detoxification in 1970-1975 and psychotherapy-assisted detoxification showed modest but consistently greater completion rates in the two eras during which it was studied, 1970-1975 and 1976-1980. The consistent gains in detoxification completion rates over the three eras are attributed primarily to the use of new drugs which greatly shorten the detoxification interval and ameliorate withdrawal symptoms. The drugs do not appear to have had an effect on follow-up abstinence rates. Limitations upon the conclusions and generalizability of findings are discussed. Suggestions are made for future methadone maintenance detoxification treatment and research.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3045260     DOI: 10.1097/00005053-198807000-00003

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  12 in total

1.  Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program.

Authors:  Zoe M Weinstein; Gabriela Gryczynski; Debbie M Cheng; Emily Quinn; David Hui; Hyunjoong W Kim; Colleen Labelle; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2018-06-19       Impact factor: 4.492

2.  Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study.

Authors:  Bohdan Nosyk; Huiying Sun; Elizabeth Evans; David C Marsh; M Douglas Anglin; Yih-Ing Hser; Aslam H Anis
Journal:  Addiction       Date:  2012-05-08       Impact factor: 6.526

Review 3.  A risk-benefit analysis of methadone maintenance treatment.

Authors:  J Bell; D Zador
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

Review 4.  Methadone maintenance treatment in opiate dependence: a review.

Authors:  M Farrell; J Ward; R Mattick; W Hall; G V Stimson; D des Jarlais; M Gossop; J Strang
Journal:  BMJ       Date:  1994-10-15

5.  Take home maintenance medication in opiate dependence.

Authors:  Stefan Gutwinski; Lena Karoline Bald; Andreas Heinz; Christian A Müller; Ane Katrin Schmidt; Corinde Wiers; Felix Bermpohl; Jürgen Gallinat
Journal:  Dtsch Arztebl Int       Date:  2013-06-10       Impact factor: 5.594

Review 6.  Supervised Injectable Heroin: A Clinical Perspective.

Authors:  James Bell; Rob van der Waal; John Strang
Journal:  Can J Psychiatry       Date:  2016-10-06       Impact factor: 4.356

Review 7.  Pharmacological maintenance treatments of opiate addiction.

Authors:  James Bell
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

8.  The long-term outcomes of drug use by methadone maintenance patients.

Authors:  Gregory Bovasso; John Cacciola
Journal:  J Behav Health Serv Res       Date:  2003 Jul-Sep       Impact factor: 1.505

Review 9.  Methadone maintenance treatment: an update.

Authors:  G Bertschy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

10.  Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatment.

Authors:  Stefan Gutwinski; Nikola Schoofs; Heiner Stuke; Thomas G Riemer; Corinde E Wiers; Felix Bermpohl
Journal:  Harm Reduct J       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.